Clinical trial
Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations
NCT00115492
Study timeline
Study start (unknown)2004-12-01Date precision: month
Registry last updated2017-01-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Interventions
SalmeterolDRUG · verified · RxNorm: salmeterol
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
San AntonioTexas, United States2PittsburghPennsylvania, United States2OmahaNebraska, United States2EvansvilleIndiana, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San DiegoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00115492 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.